AB-Core K Hepatitis B Core Antigen 125I
by Sorin Biomedica, Fiat, USA, Inc.
PMA P850044
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP850044 | Date17 Feb 1987 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Generic Name
- Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)
- PMA Number
- FDA Product Code
- LOM
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.3172
- Advisory Committee
- Microbiology
- FDA Decision
- APPR Approved
- PMA Supplement
- S003 (Normal 180 Day Track)
Overview
AI-generated summary, 18 Sep 2026
The AB-Core K Hepatitis B Core Antigen 125I is a diagnostic test designed to detect antibodies against the hepatitis B core antigen (anti-HBc). This radioimmunoassay employs a labeled antigen to identify serological markers associated with hepatitis B virus infection, aiding in the assessment of past or ongoing exposure.
This device is supplied as a kit for in vitro diagnostic use in clinical microbiology laboratories. It is intended for single-use and requires proper handling of radioactive iodine-125 (125I) labeled components, adhering to radiation safety protocols. The test is authorized under FDA Premarket Approval (PMA) with PMA number P850044 and falls under device class II (LOM product code). Storage and use must comply with regulatory requirements for radioactive materials and diagnostic assays.
Other devices from Sorin Biomedica, Fiat, USA, Inc.
Questions
AI-generated answers, 18 Sep 2026
What is the AB-CORE K Hepatitis B Core Antigen 125I test used for in clinical practice?
This test detects antibodies against the hepatitis B core antigen (anti-HBc) to assess past or ongoing exposure to the hepatitis B virus. It helps clinicians evaluate serological markers linked to infection, aiding in diagnostic decision-making for hepatitis B.
How is the AB-CORE K Hepatitis B Core Antigen 125I test supplied, and what safety precautions must be followed?
The test is supplied as a single-use kit for in vitro diagnostic use in clinical microbiology laboratories. Due to the presence of radioactive iodine-125 (125I), strict radiation safety protocols must be followed during handling, storage, and disposal to comply with regulatory requirements.
Is this device reusable, or is it intended for single-use only?
The AB-CORE K Hepatitis B Core Antigen 125I is explicitly designed for single-use only. Reuse is not permitted, particularly due to the radioactive components, which necessitate careful disposal after one use to ensure safety and compliance.
What regulatory pathway was followed for this device’s approval, and what class does it fall under?
The device was authorized under the FDA Premarket Approval (PMA) pathway with PMA number P850044. It is classified as a Class II medical device under the LOM (Laboratory and Other Diagnostic Substances) product code, reflecting its specialized diagnostic purpose.
Are there any specific storage requirements for this test kit beyond standard laboratory conditions?
While the data does not specify exact storage conditions, the kit contains radioactive materials (125I), so storage must comply with regulatory requirements for radioactive substances—typically including shielding, controlled access, and adherence to local/national radiation safety guidelines. Always refer to the manufacturer’s instructions for precise details.